Future Earnings And Recovery Prospects Will Remain Under Pressure Amid Market Challenges

Key Takeaways

• Focus on specialty polymers, cost-reduction, and global diversification positions Synthomer to achieve better margins, stable earnings, and long-term growth in sustainable markets.
  
• Expansion into eco-friendly products and high-growth regions leverages regulatory trends and urbanization, supporting multi-year revenue and margin improvement.
  
• High leverage, slow market growth, overcapacity, shifting sustainability demands, and geopolitical risks constrain Synthomer's growth, margins, and ability to invest in innovation.

Catalysts

Manufactures and supplies specialised polymers and ingredients for coatings, construction, adhesives, and health and protection sectors.

• The company's active pivot toward higher-value, specialty polymers-evidenced by the ongoing divestment of noncore, lower-margin businesses, portfolio simplification, and site rationalization-positions Synthomer to capitalize on long-term demand for sustainable and innovative chemicals. This shift is likely to enhance revenue quality, boost EBITDA margins, and support earnings growth by increasing pricing power and market relevance in growth segments.
  
• Significant cost-reduction initiatives, alongside ongoing process automation and supply chain efficiencies, are generating higher operating leverage and margin improvement (e.g., a 110 bps gross margin gain YoY). As these cost programs deliver additional run-rate savings through 2026, Synthomer is set to unlock structural margin expansion and stronger free cash flow.
  
• Emerging sustainability-related opportunities (such as ISCC+ certification, innovation in bio-based and biodegradable polymers, and marquee partnerships like Henkel) directly position Synthomer to benefit from regulatory and customer demand for low-emission, circular, and environmentally friendly products. This will drive new specialty product launches and open up higher-margin revenue streams.
  
• Global trends toward urbanization, infrastructure investment, and healthcare spending (especially in Asia and emerging markets) are long-term tailwinds for demand in construction chemicals, adhesives, and medical/hygiene materials-core focus areas for Synthomer. This supports multi-year revenue growth potential as these markets recover and expand.
  
• Geographical diversification and targeted capacity investments in the U.S. and Middle East, coupled with a more balanced sales mix, are reducing exposure to slower-growth European markets and volatile sectors, thereby improving earnings stability and providing a platform for medium-term top-line growth and improved net margins.

Synthomer Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

• Analysts are assuming Synthomer's revenue will remain fairly flat over the next 3 years.
• Analysts are not forecasting that Synthomer will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate Synthomer's profit margin will increase from -4.0% to the average GB Chemicals industry of 10.4% in 3 years.
• If Synthomer's profit margin were to converge on the industry average, you could expect earnings to reach £195.7 million (and earnings per share of £1.2) by about April 2029, up from -£75.9 million today.
• In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 1.5x on those 2029 earnings, up from -0.8x today. This future PE is lower than the current PE for the GB Chemicals industry at 18.4x.
• Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 13.21%, as per the Simply Wall St company report.

Risks

• Synthomer's high leverage and elevated net debt (with net debt to EBITDA at 4.8x and a suspended dividend until leverage falls below 3x) leave the company vulnerable to prolonged weak demand or cyclical downturns, constraining its ability to invest in growth and innovation, and putting pressure on earnings and cash flow.
  
• The company's heavy exposure to Europe (nearly 50% of sales) in slow-growing, mature markets facing tightening environmental regulations could accelerate margin erosion and limit revenue growth, especially as the strategic shift toward the US and Asia is gradual and exposed to external risks.
  
• Persistent industry overcapacity-especially in synthetic latex and emulsion polymers-combined with volatile or subdued end-market demand (notably in oil & gas, energy solutions, and nitrile for gloves), threatens sustained price competition and weaker revenues and profitability well beyond 2025.
  
• Ongoing regulatory and consumer shifts toward sustainability and bio-based/biodegradable alternatives may erode Synthomer's traditional customer base in petrochemical-based products, requiring costly R&D and potentially compressing margins if Synthomer cannot quickly transition its portfolio.
  
• The company remains exposed to volatile raw material costs, trade tariffs, and geopolitical supply chain risks, which could increase operating expenses, impact reliable product delivery, and compress net margins if such shocks persist or intensify.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The analysts have a consensus price target of £1.27 for Synthomer based on their expectations of its future earnings growth, profit margins and other risk factors.
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of £3.66, and the most bearish reporting a price target of just £0.59.
• In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be £1.9 billion, earnings will come to £195.7 million, and it would be trading on a PE ratio of 1.5x, assuming you use a discount rate of 13.2%.
• Given the current share price of £0.39, the analyst price target of £1.27 is 69.6% higher.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.